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95% CI: 0.56-0.94). Stronger association between EZH2 polymor-
phisms and the reduced lung cancer risk was observed particularly in 
younger age group (< 58 years). Associated polymorphisms were -
12712T>A, -4003C>G, and -529G>A in intron 1, +35558C>T in intron 
15, and +38931G>C in intron 19 (AOR = 0.65~0.68, P = 0.02~0.04). 
One haplotype (ht2) of EZH2 was signiﬁcantly associated with the 
reduced lung cancer risk in overall group (AOR = 0.72, 95% CI: 0.55-
0.93) as well as in younger age group (AOR=0.66, 95% CI: 0.45-0.96). 
Conclusion: This is the ﬁrst study to show a signiﬁcant associa-
tion between polymorphisms of the EZH2 gene and the lung cancer 
risk, particularly in younger age group. This study suggested that the 
presence of variant allele in EZH2 may be a protective factor for lung 
cancer, hence an important marker for lung cancer susceptibility.
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Mortality due to malignant diseases  increased  for about  28%   from 
1990-2002. in Serbia. Every third patient has the advanced disease at 
the time of diagnosis. 
The aim of the survey was to estimate some aspects of health system  
concerning malignant diseases, preferably lung cancer, in Serbia. The 
survey (“face to face”) on public opinion  comprised 1023 persons 
- represantative sample, 171 cancer patients (pts) - majority with lung 
cancer,  and  162 doctors- majority dealing mostly  with lung cancer: 
their  attitudes about  national health funding for malignant diseases, 
cancer patients position and problems during the disease course, pro-
vided disease-related informations to pts, and diagnostic access i.e. de-
lays. All 3 groups think that not enough money  is  provided for health 
and it is not well distributed. Doctors and pts agree that cancer pts 
position is pretty bad,  worse  than others; the most  frequent patients 
problems for both  the same: not well informed about  the disease, late 
diagnosis and  drug availability. The time from the onset of symptoms  
until referring to the doctor  was in average 182 days, and to establish 
the diagnosis additional 78 days.
Doctors ﬁnd the crucial problems to be:  going to see the doctor too 
late,  in many cases lack of adequate facilities and too many  pts who 
need it.
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Percutaneous needle biopsy for peripheral lung lesions smaller 
than 2cm performed under fluoroscopic CT guidance
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Background: With the advent of high resolution CT, the incidence of 
small lung lesions continues to increase. It is very difﬁcult to diagnose 
these lesions with conventional bronchoscopy, and partial resection just 
for diagnosis should be minimized for the patient as well as medical 
cost. While signiﬁcant improvements are being made in diagnostic 
bronchoscopy such as virtual bronchoscopy, these devices still require 
further studies. In the present study we analyzed our single institution 
experience of CT guided needle biopsy for small lung nodules. 
Methods: Retrospective analysis was done in 174 cases with lung 
lesions smaller than 2cm. Bronchoscopic diagnosis was attempted at 
least once in all cases. A semi-automatic 18G needle was used with a 
specially designed holding device, and a lead plate which effectively 
minimized radiation exposure of the physician. The patients breathed 
spontaneously throughout the procedure.
Results: 97 were males and 77 were females. Age ranged from 20 to 
91, average 63. The lesions were considered to be so called GGOs 
in 32, and nodules in 142. The lesions were diagnosed as malignant 
in 117, and non-malignant in 57. Overall accuracy was 87.4%. The 
distance from the point of skin penetration to the lesion ranged from 16 
to 112 mm, average 61mm. Pneumothorax was detected in 33 cases. 
Non had symptoms. 31 cases regressed spontaneously. We performed 
prophylactic manual aspiration in 2 cases. Hemosputum was seen in 14 
cases all of which abated spontaneously. 
Comments: At present, we consider percutaneous ﬂuoroscopic CT 
guided needle biopsy can be effective in providing diagnosis for these 
small lung lesions. Concerns still remain regarding the complication of 
air embolism, the mechanism of which is still unclear.
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Role of FDG-PET/CT in nodal staging with non-small cell lung 
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Purpose: Usefulness of ﬂuorodeoxyglucose (FDG) positron emission 
competed tomography (PET) in diagnosis of lung cancer has been 
reported. We assess the role of FDG PET/CT scan in lymph node stag-
ing of non-small cell lung cancer (NSCLC) and evaluate the maximum 
standard uptake value (SUVmax) of the primary tumor as a predictor of 
lymph node metastasis.
Patients and Method: From March 2006 to December 2006, 81 
preoperative patients with suspected or proven NSCLC were examined 
by FDG-PET/CT. We diagnosed lymph node staging and calculated 
